Skip to content

Clinical trials

Phase 1/2 Purpura, Thrombocytopenic, Idiopathic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 1/2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20141
20151
20181
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Bristol-Myers Squibb1
CRISPR Therapeutics AG1
Children's Hospital of Philadelphia1
Cullinan Therapeutics Inc.1
Eli Lilly and Company1
Gilead Sciences1
Momenta Pharmaceuticals, Inc.1
Neufeld, Ellis J, MD, PhD1
Protalex, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic10
Anemia, Hemolytic3
Anemia, Hemolytic, Autoimmune2
Thrombocytopenia2
Anemia1
Arthritis, Rheumatoid1
Autoimmune Diseases1
Autoimmune Lymphoproliferative Syndrome1
Blood Platelet Disorders1
Cytopenia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.